Heterocyclic inhibitors of dihydrodipicolinate synthase are not competitive.

Bioorg Med Chem 2005 Mar;13(6):2133-40

School of Chemistry, University of Sydney, Sydney, NSW 2006, Australia.

A series of piperidine- and pyridine-2,6-dicarboxylate derivatives has been evaluated as potential inhibitors of dihydrodipicolinate synthase (DHDPS). The compounds were designed with oxygen functionality at the C-4 position in order to mimic the putative enzyme product HTHDP. Most compounds displayed weak-moderate inhibition of DHDPS. Additionally, the most potent inhibitors were shown not to be competitive, indicating they do not bind at the active site. Discrepancies between the two common assay systems-the imidazole assay and the coupled assay-were observed which are attributed to inherent problems in the imidazole assay, leading to artefactually low K(i) measurements.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2005.01.001DOI Listing
March 2005
4 Reads

Publication Analysis

Top Keywords

imidazole assay
8
inhibitors dihydrodipicolinate
8
dihydrodipicolinate synthase
8
bind active
4
additionally potent
4
dhdps additionally
4
potent inhibitors
4
inhibitors competitive
4
competitive indicating
4
inhibition dhdps
4
indicating bind
4
displayed weak-moderate
4
putative enzyme
4
mimic putative
4
order mimic
4
enzyme product
4
product hthdp
4
active site
4
hthdp compounds
4
weak-moderate inhibition
4

Similar Publications